Vyome Therapeutics Inc CEO Venkat Nelabhotla sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.
Vyome Therapeutics is a clinical stage speciality pharmaceutical company, with platform technologies and a pipeline of drugs for antibiotic-resistant acne and other skin pathogens.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Blackrock Gold (CVE: BRC) CEO Andrew Pollard joined Steve Darling from Proactive Vancouver to discuss a number of things happening with the company including Blackrock adding a new member to their board of directors. Pollard talking about what he likes about David Laing. Pollard also telling...
Retail & consumer
Full interview: Naturally Splendid hits major milestone with...
Health
Health
Prev article
